TMCnet News
Solubilization Formulations Using Polyvinyl Acetate Phthalate (PVAP) as a Dispersion PolymerBEND, Ore. --(Business Wire)-- Agere Pharmaceuticals, Inc., a leading oral bioavailability contract research and manufacturing organization (CRMO), announced today that it will present case studies on spray drying of poorly soluble Active Pharmaceutical Ingredients (APIs) utilizing PVAP as a dispersion polymer excipient for enhancing bioavailability. The presentation will be made in conjunction with BUCHI Corporation as part of an interactive webinar focusing on current trends in laboratory spray drying. The event is sponsored by American Pharmaceutical Review, the leading review journal for business and technology in the pharmaceutical industry throughout North America.
About Agere Agere is a leading CRMO focused on improving the oral bioavailability of insoluble APIs. The company supports clients from formulation design and development through cGMP manufacturing for Phase I through Phase IIb clinical trials. Agere is expert in solid dispersion techniques including spray drying and hot melt extrusion (HME), and in a broad selection of solid dosage forms. All services are delivered on a fee-for-service basis, and every project the company undertakes is customized to serve each individual client's requirements. Agere is located in Bend, OR. www.agerepharma.com. Agere Pharmaceuticals is a trademark owned by Agere Pharmaceuticals, Inc. All other trademarks are the property of their respective owners. |
